JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, J.
Right arrow Articles by Wessling-Resnick, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, J.
Right arrow Articles by Wessling-Resnick, M.

J Biol Chem, Vol. 273, Issue 52, 34675-34678, December 25, 1998

COMMUNICATION
Expression of SFT (Stimulator of Fe Transport) Is Enhanced by Iron Chelation in HeLa Cells and by Hemochromatosis in Liver

Jianming Yu, Zhong Kang Yu, and Marianne Wessling-Resnick

From the Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts 02115

SFT (stimulator of Fe transport) is a novel transport protein that has been found to facilitate uptake of iron presented to cells as either Fe(II) or Fe(III). When HeLa cells are exposed to the iron chelator desferrioxamine, levels of SFT mRNA increase in an actinomycin D-sensitive manner. In contrast, cells exposed to high levels of iron down-regulate SFT expression in a time-dependent and reversible fashion. Thus, homeostatic regulation of SFT expression not only ensures that sufficient levels of iron are maintained but also limits excessive assimilation to prevent potentially harmful effects of this toxic metal. The unexpected observation that SFT transcript levels are up-regulated in hemochromatosis patients therefore suggests that enhanced SFT expression contributes to the etiology of this iron overload disorder.

Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.


This article has been cited by other articles:


Home page
 BloodHome page
S. G. Gehrke, H.-D. Riedel, T. Herrmann, B. Hadaschik, K. Bents, C. Veltkamp, and W. Stremmel
UbcH5A, a member of human E2 ubiquitin-conjugating enzymes, is closely related to SFT, a stimulator of iron transport, and is up-regulated in hereditary hemochromatosis
Blood, April 15, 2003; 101(8): 3288 - 3293.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. D. Knutson, J. E. Levy, N. C. Andrews, and M. Wessling-Resnick
Expression of Stimulator of Fe Transport Is Not Enhanced in Hfe Knockout Mice
J. Nutr., May 1, 2001; 131(5): 1459 - 1464.
[Abstract] [Full Text]

Home page
 Am. J. Clin. Nutr.Home page
J. Tallkvist, C. L Bowlus, and B. Lonnerdal
Functional and molecular responses of human intestinal Caco-2 cells to iron treatment
Am. J. Clinical Nutrition, September 1, 2000; 72(3): 770 - 775.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
Z. L. Harris, A. P. Durley, T. K. Man, and J. D. Gitlin
Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux
PNAS, September 14, 1999; 96(19): 10812 - 10817.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.